Abiopharma

🔍 Ye Gang (Executive)

Company: Sea Ltd (SE)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Sold 2,696 shares of Class A ordinary shares at $117.7 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 406,096.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 6,654 shares of Class A ordinary shares at $118.32 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 399,442.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,464 shares of Class A ordinary shares at $119.44 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 396,978.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 11,725 shares of Class A ordinary shares at $120.14 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 385,253.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 2,419 shares of Class A ordinary shares at $121.65 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 382,834.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,770 shares of Class A ordinary shares at $122.6 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 381,064.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 2,272 shares of Class A ordinary shares at $123.17 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: false | shares_owned_after: 378,792.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 10,454 shares of Class A ordinary shares at $119.23 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 368,338.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 10,039 shares of Class A ordinary shares at $120.28 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 358,299.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 9,397 shares of Class A ordinary shares at $121.13 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 348,902.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 110 shares of Class A ordinary shares at $121.68 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 348,792.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A ordinary shares (Direct)
  Date: 2026-08-25 | Code: H | shares_owned_after: 20,976,405.00

Footnotes:

• F1: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by a BVI entity controlled by the Reporting Person on September 4, 2025.
• F2: Represents the weighted average price of shares sold at prices that ranged from $117.00 to $117.9988. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
• F3: Represents the weighted average price of shares sold at prices that ranged from $118.00 to $118.87.
• F4: Represents the weighted average price of shares sold at prices that ranged from $119.01 to $119.999.
• F5: Represents the weighted average price of shares sold at prices that ranged from $120.00 to $120.95.
• F6: Represents the weighted average price of shares sold at prices that ranged from $121.01 to $121.96.
• F7: Represents the weighted average price of shares sold at prices that ranged from $122.14 to $123.00.
• F8: Represents the weighted average price of shares sold at prices that ranged from $123.05 to $123.42.
• F9: Represents the weighted average price of shares sold at prices that ranged from $118.64 to $119.63.
• F10: Represents the weighted average price of shares sold at prices that ranged from $119.64 to $120.63.
• F11: Represents the weighted average price of shares sold at prices that ranged from $120.64 to $121.44.